Quality Certification
- Categories:Quality Registration
- Time of issue:2021-05-28 16:42:44
- Views:0
Description:
Information
In December 2012, the raw material (Norfloxacin) passed the on-site GMP inspection of KFDA in South Korea.
In February 2013, the raw material (Norfloxacin) passed the on-site GMP inspection of Jazmp in Slovenia.
In January 2014, tablets and capsules passed the new version of CFDA GMP certification.
In April 2014, 6 APIs passed the new version of CFDA GMP certification.
In August 2014, it passed the on-site CGMP re-certification of the US FDA.
In February 2015, the new workshop of the raw material medicine (atorvastatin calcium) passed the new version of CFDA GMP certification.
In July 2015, the raw material (linezolid) passed Mexico's COFEPRIS GMP certification.
In February 2018, the tablet (301-3 production line) passed the new version of CFDA GMP certification.
In August 2018, the tablet (902 workshop) passed the new version of CFDA GMP certification.
Search for
LINKS：
Copyright © 2021 Zhejiang LePu Pharmaceutical Co., Ltd. All rights reserved 浙ICP备17026965号 Powered by www.300.cn